REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P953. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 32,400 | -4.1% | 0.00% | -100.0% |
| Q2 2023 | $3,446 | -50.5% | 33,800 | -55.9% | 0.00% | -50.0% |
| Q1 2023 | $6,964 | +1482.7% | 76,600 | +560.3% | 0.01% | – |
| Q4 2022 | $440 | -100.0% | 11,600 | -93.8% | 0.00% | -100.0% |
| Q3 2022 | $4,684,000 | +414.2% | 186,400 | +521.3% | 0.01% | +400.0% |
| Q2 2022 | $911,000 | -81.5% | 30,000 | -80.1% | 0.00% | -80.0% |
| Q1 2022 | $4,930,000 | +523.3% | 150,500 | +401.7% | 0.01% | +400.0% |
| Q4 2021 | $791,000 | -85.7% | 30,000 | -22.3% | 0.00% | -80.0% |
| Q3 2021 | $5,520,000 | +1.0% | 38,600 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $5,463,000 | +32.1% | 38,600 | +9201.2% | 0.01% | -28.6% |
| Q1 2021 | $4,137,000 | +6682.0% | 415 | +8200.0% | 0.01% | – |
| Q4 2020 | $61,000 | -89.6% | 5 | -91.7% | 0.00% | -100.0% |
| Q3 2020 | $584,000 | +120.4% | 60 | +252.9% | 0.00% | – |
| Q2 2020 | $265,000 | -60.0% | 17 | -63.0% | 0.00% | -100.0% |
| Q1 2020 | $663,000 | -70.5% | 46 | -58.2% | 0.00% | -80.0% |
| Q4 2019 | $2,248,000 | +145.7% | 110 | -3.5% | 0.01% | +66.7% |
| Q3 2019 | $915,000 | +1846.8% | 114 | +2180.0% | 0.00% | – |
| Q2 2019 | $47,000 | -66.4% | 5 | -80.0% | 0.00% | – |
| Q4 2018 | $140,000 | -62.8% | 25 | -45.7% | 0.00% | -100.0% |
| Q3 2018 | $376,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 25 | $140,000 | 0.00% |